BIOMAT Database Logo BIOMAT Database Logo

Intraperitoneal kanamycin; comparison with other antibiotics administered intraperitoneally. 1958

I COHN, and B M BEAUCLAIR

UI MeSH Term Description Entries
D007612 Kanamycin Antibiotic complex produced by Streptomyces kanamyceticus from Japanese soil. Comprises 3 components: kanamycin A, the major component, and kanamycins B and C, the minor components. Kanamycin A,Kanamycin Sulfate,Kantrex
D003879 Dermatologic Agents Drugs used to treat or prevent skin disorders or for the routine care of skin. Agent, Dermatologic,Agent, Dermatological,Agents, Dermatologic,Dermatologic Agent,Dermatological Agents,Agents, Dermatological,Dermatological Agent
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D000904 Antibiotics, Antitubercular Substances obtained from various species of microorganisms that are, alone or in combination with other agents, of use in treating various forms of tuberculosis; most of these agents are merely bacteriostatic, induce resistance in the organisms, and may be toxic. Antitubercular Antibiotics

Related Publications

I COHN, and B M BEAUCLAIR
Absorption and excretion of intraperitoneally administered kanamycin sulfate.
June 1972, Surgery, gynecology & obstetrics,
I COHN, and B M BEAUCLAIR
In vitro effectiveness of kanamycin and kanamycin/cephalothin against Klebsiella. Comparison with other antibiotics.
September 1967, Annals of internal medicine,
I COHN, and B M BEAUCLAIR
Intraperitoneal kanamycin.
April 1962, Annals of surgery,
I COHN, and B M BEAUCLAIR
Susceptibility of Salmonellae to kanamycin and other antibiotics.
June 1960, Antibiotics & chemotherapy (Northfield, Ill.),
I COHN, and B M BEAUCLAIR
Patterns of organisms in disease and in vitro sensitivity to kanamycin in comparison with other antibiotics.
June 1966, Annals of the New York Academy of Sciences,
I COHN, and B M BEAUCLAIR
Melphalan and cytarabine administered intraperitoneally as single agents and combination intraperitoneal chemotherapy with cisplatin and cytarabine.
September 1985, Seminars in oncology,
I COHN, and B M BEAUCLAIR
Enhanced effectiveness of intraperitoneal antibiotics administered via liposomal carrier.
December 1989, Archives of surgery (Chicago, Ill. : 1960),
I COHN, and B M BEAUCLAIR
A comparison of the in vitro effectiveness of kanamycin and nine other antibiotics against staphylococci.
July 1959, Antibiotics & chemotherapy (Northfield, Ill.),
I COHN, and B M BEAUCLAIR
INTRAPERITONEAL KANAMYCIN-- CLINICAL EXPERIENCE.
November 1963, The American surgeon,
I COHN, and B M BEAUCLAIR
[Antibacterial activity of ristocetin, kanamycin and farmiglucine in association with other antibiotics].
December 1964, Bollettino della Societa italiana di biologia sperimentale,
Copied contents to your clipboard!